These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11155214)

  • 1. Hyperhomocysteinemia in type 2 diabetes mellitus: cardiovascular risk factors and effect of treatment with folic acid and pyridoxine.
    Baliga BS; Reynolds T; Fink LM; Fonseca VA
    Endocr Pract; 2000; 6(6):435-41. PubMed ID: 11155214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study.
    de Jong SC; Stehouwer CD; van den Berg M; Geurts TW; Bouter LM; Rauwerda JA
    J Intern Med; 1999 Jul; 246(1):87-96. PubMed ID: 10447230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
    Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
    Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia.
    van den Berg M; Franken DG; Boers GH; Blom HJ; Jakobs C; Stehouwer CD; Rauwerda JA
    J Vasc Surg; 1994 Dec; 20(6):933-40. PubMed ID: 7990188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of vitamin-optimized plasma homocysteine cutoff values on the prevalence of hyperhomocysteinemia in healthy adults.
    Fokkema MR; Weijer JM; Dijck-Brouwer DA; van Doormaal JJ; Muskiet FA
    Clin Chem; 2001 Jun; 47(6):1001-7. PubMed ID: 11375284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of total homocysteine-lowering drugs on cardiovascular disease.
    Sunder-Plassmann G; Winkelmayer WC; Födinger M
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2637-51. PubMed ID: 11060826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of different treatment regimens in reducing fasting and postmethionine-load homocysteine concentrations.
    van der Griend R; Biesma DH; Haas FJ; Faber JA; Duran M; Meuwissen OJ; Banga JD
    J Intern Med; 2000 Sep; 248(3):223-9. PubMed ID: 10971789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No effect of B vitamins on ADMA levels in patients at increased cardiovascular risk.
    Spoelstra-de Man AM; Teerlink T; Brouwer CB; Rauwerda JA; Stehouwer CD; Smulders YM
    Clin Endocrinol (Oxf); 2006 May; 64(5):495-501. PubMed ID: 16649966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.
    Vermeulen EG; Stehouwer CD; Twisk JW; van den Berg M; de Jong SC; Mackaay AJ; van Campen CM; Visser FC; Jakobs CA; Bulterjis EJ; Rauwerda JA
    Lancet; 2000 Feb; 355(9203):517-22. PubMed ID: 10683000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives.
    van der Griend R; Haas FJ; Biesma DH; Duran M; Meuwissen OJ; Banga JD
    Atherosclerosis; 1999 Mar; 143(1):177-83. PubMed ID: 10208493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
    Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
    Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R; Armitage J
    Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
    Ventura P; Panini R; Emiliani S; Salvioli G
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):44-51. PubMed ID: 14758571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia.
    Levine J; Stahl Z; Sela BA; Ruderman V; Shumaico O; Babushkin I; Osher Y; Bersudsky Y; Belmaker RH
    Biol Psychiatry; 2006 Aug; 60(3):265-9. PubMed ID: 16412989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced pertubation of the aminothiol redox-status in patients with epilepsy: improvement by B-vitamins.
    Apeland T; Frøyland ES; Kristensen O; Strandjord RE; Mansoor MA
    Epilepsy Res; 2008 Nov; 82(1):1-6. PubMed ID: 18644700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation.
    Undas A; Domagala TB; Jankowski M; Szczeklik A
    Thromb Res; 1999 Sep; 95(6):281-8. PubMed ID: 10527405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocysteinaemia is not associated with increased levels of asymmetric dimethylarginine in patients with ischaemic heart disease.
    Jonasson TF; Hedner T; Hultberg B; Ohlin H
    Eur J Clin Invest; 2003 Jul; 33(7):543-9. PubMed ID: 12814389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia in organ transplantation.
    Sunder-Plassmann G; Floth A; Födinger M
    Curr Opin Urol; 2000 Mar; 10(2):87-94. PubMed ID: 10785848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.